Literature DB >> 22853840

Petrosal approaches to posterior circulation aneurysms.

Bradley A Gross1, Daryoush Tavanaiepour, Rose Du, Ossama Al-Mefty, Ian F Dunn.   

Abstract

Complex posterior circulation aneurysms are formidable lesions with an abysmal natural history. Their management continues to present a challenge to both endovascular and open microsurgical approaches. Affording an expansive, combined supra- and infratentorial exposure, the petrosal approaches are well suited for these challenging lesions when located along the basilar trunk or at a low-lying basilar apex. This report evaluates the evolution and application of petrosal approaches to these lesions. Excluding transsigmoid, infratentorial, or labyrinth-sacrificing approaches, the authors found 23 reports with 61 posterior circulation aneurysms treated via a petrosal approach. Although early morbidity was not negligible, rates of aneurysm occlusion (95% overall) and long-term outcome were quite laudable in light of the challenge posed by these lesions. Moreover, with accumulating experience with petrosal approaches, rates of complications are likely to wane, as neurosurgeons capitalize on the expansive exposure afforded by these indispensable approaches.

Entities:  

Mesh:

Year:  2012        PMID: 22853840     DOI: 10.3171/2012.6.FOCUS12131

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  2 in total

1.  Advantages of petrosectomy for superficial temporal artery to superior cerebellar artery bypass based on three-dimensional distance measurements using cadaver heads.

Authors:  Kenji Uda; Kuniaki Tanahashi; Takashi Mamiya; Fumiaki Kanamori; Kinya Yokoyama; Masahiro Nishihori; Takashi Izumi; Yoshio Araki; Ryuta Saito
Journal:  Neurosurg Rev       Date:  2021-11-04       Impact factor: 3.042

2.  The Bigger the Better? Analysis of Surgical Complications and Outcome of the Retrosigmoid Approach in 449 Oncological Cases.

Authors:  Amir Kaywan Aftahy; Ann-Kathrin Jörger; Sandra Hillebrand; Felix N Harder; Benedikt Wiestler; Denise Bernhardt; Stephanie E Combs; Bernhard Meyer; Chiara Negwer; Jens Gempt
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.